Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia. [PDF]
Lindenbach D +4 more
europepmc +1 more source
Dyskinesia following modafinil administration in a patient with autism spectrum disorder and narcolepsy: a case report. [PDF]
Niijima K +3 more
europepmc +1 more source
Pharmacovigilance analysis of central nervous system adverse events associated with sevoflurane and drug interactions: a disproportionality study based on the FDA adverse event reporting system (FAERS) database. [PDF]
Yu H, Wang B.
europepmc +1 more source
Utilising human cellular models of primary ciliary dyskinesia: a scoping review. [PDF]
Ong JWY +4 more
europepmc +1 more source
Heterogeneity in adverse events associated with lumateperone: a study on potential subgroup-specific differences. [PDF]
Jiang C, Tang L, Li M, Xia G.
europepmc +1 more source
Movement disorder emergencies at a tertiary-care center in West Bengal, India: Spectrum, etiologies, diagnostic implications. [PDF]
Manna DK +7 more
europepmc +1 more source
Phenotypic features of paroxysmal dyskinesia in Dachshund dogs: 62 cases (2017-2025). [PDF]
Boyd B +17 more
europepmc +1 more source
Deutetrabenazine in Hyperkinetic Movement Disorders: VMAT2 Modulation From Choreiform Disorders to Hyperkinetic Dystonic Syndromes. [PDF]
Fang Y, Lu Y, Zhu S, Huang S.
europepmc +1 more source
Reclassification of Exercise-Induced Arrhythmogenic Cardiomyopathy: Detection of a Pathogenic PKP2 Variant in a Male Athlete. [PDF]
Tramèr L +8 more
europepmc +1 more source

